Bioprocessing - Upstream & Downstream

How metabolic conditioning could improve cell therapy potency and persistence.

Cryogenic freezing performed too fast can damage biopharma products. What’s the best way forward? An expert gives their view.

Progress in Alzheimer’s Disease research, but a cure will take time. Delaying it and disseminating that research may buy scientists the time they need

Biopharma tech continues to advance so why is downstream processing such a headache?

Lipid nanoparticles are a cornerstone of mRNA therapeutics. For manufacturing, will you choose stainless steel or single-use?

Looking at key milestones, challenges, and innovations in cell culture media – and what lies in store ahead.

CRISPR tech in antibody manufacturing, sterilization of single-use systems, and more! Check out our eBook.

Why is the stable pools approach attracting more attention in the cell line development space?

Academia has its appeal for many; for others the real challenges are in industry. Here, IO Biotech CEO Mai-Britt Zocca discusses her own motivations.

Gene therapy approvals have come thick and fast in 2023. Now let’s talk about how we can ramp up manufacturing speed with platform processes.